147 related articles for article (PubMed ID: 30478299)
41. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
[TBL] [Abstract][Full Text] [Related]
42. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
[TBL] [Abstract][Full Text] [Related]
43. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
44. Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo.
Li CC; Yu FS; Fan MJ; Chen YY; Lien JC; Chou YC; Lu HF; Tang NY; Peng SF; Huang WW; Chung JG
Environ Toxicol; 2017 Mar; 32(3):723-738. PubMed ID: 27113412
[TBL] [Abstract][Full Text] [Related]
45. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
[TBL] [Abstract][Full Text] [Related]
46. Cantharidin inhibits melanoma cell proliferation via the miR‑21‑mediated PTEN pathway.
Mu Z; Sun Q
Mol Med Rep; 2018 Nov; 18(5):4603-4610. PubMed ID: 30221692
[TBL] [Abstract][Full Text] [Related]
47. DA-9601, a standardized extract of Artemisia asiatica, blocks TNF-alpha-induced IL-8 and CCL20 production by inhibiting p38 kinase and NF-kappaB pathways in human gastric epithelial cells.
Choi SC; Choi EJ; Oh HM; Lee S; Lee JK; Lee MS; Shin YI; Choi SJ; Chae JR; Lee KM; Lee WJ; Park JS; Shin CY; Oh TY; Jun CD
World J Gastroenterol; 2006 Aug; 12(30):4850-8. PubMed ID: 16937467
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis.
Bai X; Zhi X; Zhang Q; Liang F; Chen W; Liang C; Hu Q; Sun X; Zhuang Z; Liang T
Cancer Lett; 2014 Dec; 355(2):281-7. PubMed ID: 25304380
[TBL] [Abstract][Full Text] [Related]
49. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
[TBL] [Abstract][Full Text] [Related]
50. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
51. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells.
Chen QJ; Zhang MZ; Wang LX
Cell Physiol Biochem; 2010; 26(6):849-58. PubMed ID: 21220916
[TBL] [Abstract][Full Text] [Related]
52. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
53. Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation.
Zhang X; Lin CC; Chan WK; Liu KL; Yang ZJ; Zhang HQ
Molecules; 2017 Jun; 22(7):. PubMed ID: 28672816
[TBL] [Abstract][Full Text] [Related]
54. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional responses to cantharidin, a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple signal transduction pathways.
Bajsa J; Pan Z; Duke SO
Physiol Plant; 2011 Oct; 143(2):188-205. PubMed ID: 21668865
[TBL] [Abstract][Full Text] [Related]
56. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
57. Cantharidin-binding protein: identification as protein phosphatase 2A.
Li YM; Casida JE
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11867-70. PubMed ID: 1334551
[TBL] [Abstract][Full Text] [Related]
58. [Comparative study of antitumor activity of cantharidin and cantharis peptides].
Liao XY; Lu SG; Feng JF
Zhong Yao Cai; 2013 Oct; 36(10):1566-9. PubMed ID: 24761662
[TBL] [Abstract][Full Text] [Related]
59. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
[TBL] [Abstract][Full Text] [Related]
60. Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.
Lee FY; Covello KL; Castaneda S; Hawken DR; Kan D; Lewin A; Wen ML; Ryseck RP; Fairchild CR; Fargnoli J; Kramer R
Clin Cancer Res; 2008 Dec; 14(24):8123-31. PubMed ID: 19088027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
